Bullous acral erythema secondary to high-dose methotrexate

Journal of Pediatric Hematology/Oncology

Volumn 24, Issue 3, 2002, Pages 240-

  Morrell, Dean S ^a   Challgren, Eric ^a   Eapen, Mary ^a   Esterly, Nancy B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CORTICOSTEROID; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

ADOLESCENT; BULLOUS SKIN DISEASE; CASE REPORT; CLINICAL EXAMINATION; DRUG ELIMINATION; DRUG MEGADOSE; ERYTHEMA; HUMAN; LETTER; MALE; OSTEOSARCOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; BONE NEOPLASMS; ERYTHEMA; HUMANS; MALE; METHOTREXATE; OSTEOSARCOMA; SKIN DISEASES, VESICULOBULLOUS;

EID: 0036214410     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200203000-00018     Document Type: Letter

References (8)

1. High-dose methotrexate-induced bullous variant of acral erythema
2. Acral erythema in children receiving high-dose methotrexate
3. Chemotherapy-induced acral erythema
4. Erythema and desquamation after high-dose methotrexate
5. Acral erythema associated with high-dose methotrexate infusion
6. Acral erythema secondary to high-dose cytosine arabinoside with pain worsened by cyclosporine infusions
7. Treatment of cytarabine acral erythema with corticosteroids
8. Pyroxidine for the palmar-plantar erythrodysesthesia syndrome